GOLDMAN SACHS GROUP INC - 31 Dec 2025 SCHEDULE 13G/A Report for INTELLIA THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (NTLA)

Filing Manager
GOLDMAN SACHS GROUP INC
Reporting Manager
THE GOLDMAN SACHS GROUP, INC.
Security
INTELLIA THERAPEUTICS, INC. Common Stock, par value $0.0001 per share
Symbol
NTLA
Shares outstanding
116,932,531 shares
Disclosed Ownership
3,157,178 shares
Ownership
2.7%
Form type
SCHEDULE 13G/A
Filing time
12 Feb 2026, 14:39:36 UTC
Date of event
31 Dec 2025
Previous filing
12 Nov 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"GOLDMAN SACHS GROUP INC disclosed 2.7% ownership in INTELLIA THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (NTLA) on 31 Dec 2025."

Quick Takeaways

  • GOLDMAN SACHS GROUP INC filed SCHEDULE 13G/A for INTELLIA THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (NTLA).
  • Disclosed ownership: 2.7%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 12 Nov 2025.
  • Current filing was accepted on 12 Feb 2026, 14:39.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
THE GOLDMAN SACHS GROUP, INC. 2.7% 3,157,178 0 3,156,786 Name: Abhilasha Bareja Attorney-in-fact
GOLDMAN SACHS & CO. LLC 2.7% 3,157,178 0 3,156,786 Name: Abhilasha Bareja Attorney-in-fact

Sponsored